Literature DB >> 24105643

Small vessel disease and memory loss: what the clinician needs to know to preserve patients' brain health.

Christian Schenk1, Timothy Wuerz, Alan J Lerner.   

Abstract

Small vessel disease (SVD) in the brain manifests in the periventricular and deep white matter and radiographically is described as "leukoaraiosis". It is increasingly recognized as a cause of morbidity from middle age onward and this clinical relevance has paralleled advances in the field of neuroradiology. Overall, SVD is a heterogenous group of vascular disorders that may be asymptomatic, or a harbinger of many conditions that jeopardize brain health. Management and prevention focuses on blood pressure control, lifestyle modification, and symptomatic treatment.

Entities:  

Mesh:

Year:  2013        PMID: 24105643     DOI: 10.1007/s11886-013-0427-6

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  190 in total

Review 1.  The association of chronic kidney disease with brain lesions on MRI or CT: a systematic review.

Authors:  Sanne C M Vogels; Marielle H Emmelot-Vonk; Harald J J Verhaar; Huiberdina Dineke L Koek
Journal:  Maturitas       Date:  2012-02-10       Impact factor: 4.342

Review 2.  Hypertension and cognitive function in the elderly.

Authors:  Antonio Cherubini; David T Lowenthal; Esther Paran; Patrizia Mecocci; Leonard S Williams; Umberto Senin
Journal:  Dis Mon       Date:  2010-03       Impact factor: 3.800

Review 3.  Genetics of ageing-related changes in brain white matter integrity - a review.

Authors:  Sri C Kanchibhotla; Karen A Mather; Wei Wen; Peter R Schofield; John B J Kwok; Perminder S Sachdev
Journal:  Ageing Res Rev       Date:  2012-11-02       Impact factor: 10.895

4.  Changes in normal-appearing white matter precede development of white matter lesions.

Authors:  Marius de Groot; Benjamin F J Verhaaren; Renske de Boer; Stefan Klein; Albert Hofman; Aad van der Lugt; M Arfan Ikram; Wiro J Niessen; Meike W Vernooij
Journal:  Stroke       Date:  2013-02-21       Impact factor: 7.914

5.  Loss of white matter integrity is associated with gait disorders in cerebral small vessel disease.

Authors:  Karlijn F de Laat; Anil M Tuladhar; Anouk G W van Norden; David G Norris; Marcel P Zwiers; Frank-Erik de Leeuw
Journal:  Brain       Date:  2010-12-14       Impact factor: 13.501

6.  Body fat distribution as a risk factor for cerebrovascular disease: an MRI-based body fat quantification study.

Authors:  Hanna-Sofia Karcher; Robert Holzwarth; Hans-Peter Mueller; Albert C Ludolph; Roman Huber; Jan Kassubek; Elmar H Pinkhardt
Journal:  Cerebrovasc Dis       Date:  2013-04-23       Impact factor: 2.762

7.  Age-varying association between blood pressure and risk of dementia in those aged 65 and older: a community-based prospective cohort study.

Authors:  Ge Li; Isaac C Rhew; Jane B Shofer; Walter A Kukull; John C S Breitner; Elaine Peskind; James D Bowen; Wayne McCormick; Linda Teri; Paul K Crane; Eric B Larson
Journal:  J Am Geriatr Soc       Date:  2007-08       Impact factor: 5.562

8.  Regional white matter hyperintensity volume, not hippocampal atrophy, predicts incident Alzheimer disease in the community.

Authors:  Adam M Brickman; Frank A Provenzano; Jordan Muraskin; Jennifer J Manly; Sonja Blum; Zoltan Apa; Yaakov Stern; Truman R Brown; José A Luchsinger; Richard Mayeux
Journal:  Arch Neurol       Date:  2012-12

9.  Clinical symptoms and risk factors in cerebral microangiopathy patients.

Authors:  Sandra Okroglic; Catherine N Widmann; Horst Urbach; Philip Scheltens; Michael T Heneka
Journal:  PLoS One       Date:  2013-02-05       Impact factor: 3.240

10.  Vascular and Alzheimer's disease markers independently predict brain atrophy rate in Alzheimer's Disease Neuroimaging Initiative controls.

Authors:  Josephine Barnes; Owen T Carmichael; Kelvin K Leung; Christopher Schwarz; Gerard R Ridgway; Jonathan W Bartlett; Ian B Malone; Jonathan M Schott; Martin N Rossor; Geert Jan Biessels; Charlie DeCarli; Nick C Fox
Journal:  Neurobiol Aging       Date:  2013-03-21       Impact factor: 4.673

View more
  3 in total

Review 1.  Blood Pressure Control and Protection of the Aging Brain.

Authors:  Nasratullah Wahidi; Alan J Lerner
Journal:  Neurotherapeutics       Date:  2019-07       Impact factor: 7.620

2.  Claudin-1 and Claudin-3 as Molecular Regulators of Myelination in Leukoaraiosis Patients.

Authors:  Yan Chen; Zheng Zheng; Ainong Mei; Huan Huang; Fan Lin
Journal:  Clinics (Sao Paulo)       Date:  2021-05-17       Impact factor: 2.365

3.  Aging Brains Degrade Driving Safety Performances of the Healthy Elderly.

Authors:  Kaechang Park; Kazumi Renge; Yoshinori Nakagawa; Fumio Yamashita; Masahiro Tada; Yasuhiko Kumagai
Journal:  Front Aging Neurosci       Date:  2022-01-25       Impact factor: 5.750

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.